Skip to content

Targeted Delivery

Targeted delivery of nanoparticles is an area that has been intensively researched.

Targeted drug delivery has a role to play in the delivery of many if not all drugs, but targeted delivery systems are critical for the delivery of nucleic acid-based agents such as siRNA and CRISPR-Cas technology.

Unlike many other nanoparticle-based delivery systems, exosomes are easily modified to contain targeting entities to enable tissue- and organ-specific delivery. Evox has created proprietary technology and knowhow to engineer and modify exosomes to facilitate targeted drug delivery to organs of interest, not least to the brain and the central nervous system. Our R&D teams are in constant pursuit of novel targeting technologies for enhancing exosome-mediated delivery to tissues of interest and combining this with the inherent biology of exosomes to further drive optimal in vivo behaviour.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.